European Companies Search Engine
Member of the board (2) Shaba18 Oct 2016 Swiss Official Gazette of Commerce Archive, Switzerland
Overview
Text
ADC Therapeutics SA, epalinges, CHE-461.408.645 (FOSC, June 1, 2016, 0/2863963). Amended statutes on. Ordinary increase in equity. New fully released share capital: CHF 294,700, divided into 574 CHF 100 Type A registered shares, 1,141 Type B registered shares of CHF 100, 646 CHF 100 type C registered shares, preferred for liquidation and/or distribution proceeds, and 586 CHF 100 type D registered shares, privileged in terms of liquidation and/or distribution proceeds, all with restrictions on the forwardability of statutes. The General Assembly amended a statutory clause relating to an authorized capital increase (according to the decision of the) by decision of the. For details, see the statutes. The General Assembly introduced a statutory clause relating to an authorized increase in capital by decision of the. For details, see the statutes. ?????? ??????????? is now in Mont-sur-Lausanne. New director with collective signature for two: Pfisterer Thomas, from Germany, to Risch. Amended statutes on. Ordinary increase in equity. New fully released capital: CHF 295,400, divided into 574 CHF 100 Type A registered shares, 1,141 Chf 100 type B registered shares, CHF 100, 646 CHF 100 type C registered shares, preferred for liquidation and/or distribution proceeds, and 593 CHF 100 type D registered shares, privileged in terms of liquidation and/or distribution proceeds, all with restrictions on the forwardability of statutes. Daily Register No. 16517 of 18 October 2016 / CHE-461.408.645 / 03121673
This filing was translated from French to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: ADC Therapeutics SA, Epalinges, Switzerland.
